Search

Your search keyword '"Mark A. Schembri"' showing total 206 results

Search Constraints

Start Over You searched for: Author "Mark A. Schembri" Remove constraint Author: "Mark A. Schembri" Language undetermined Remove constraint Language: undetermined
206 results on '"Mark A. Schembri"'

Search Results

1. Uropathogenic Escherichia coli biofilms

2. Synthesis of a Gal-β-(1→4)-Gal disaccharide as a ligand for the fimbrial adhesin UcaD

3. Integrative omics identifies conserved and pathogen-specific responses of sepsis-causing bacteria

4. Antidepressants can induce mutation and enhance persistence toward multiple antibiotics

5. HDAC7 is an immunometabolic switch triaging danger signals for engagement of antimicrobial versus inflammatory responses in macrophages

6. Molecular and structural characterization of a novel Escherichia coli interleukin receptor mimic protein

7. Distinct ecological fitness factors coordinated by a conserved Escherichia coli regulator during systemic bloodstream infection

8. Distinct ecological fitness factors coordinated by a conserved

9. Cyclic ADP ribose isomers: Production, chemical structures, and immune signaling

10. Chemical structures of cyclic ADP ribose (cADPR) isomers and the molecular basis of their production and signaling

11. Antidepressants promote the spread of antibiotic resistance via horizontally conjugative gene transfer

12. Comprehensive analysis of IncC plasmid conjugation identifies a crucial role for the transcriptional regulator AcaB

13. Oral cephalosporin and β-lactamase inhibitor combinations for ESBL-producing Enterobacteriaceae urinary tract infections

14. Frontline Science: LPS-inducible SLC30A1 drives human macrophage-mediated zinc toxicity against intracellular Escherichia coli

15. Enhancing the Thermal and Kinetic Stability of Ketol-Acid Reductoisomerase, a Central Catalyst of a Cell-Free Enzyme Cascade for the Manufacture of Platform Chemicals

16. Ucl fimbriae regulation and glycan receptor specificity contribute to gut colonisation by extra-intestinal pathogenic Escherichia coli

17. Bacteriophage isolated from non-target bacteria demonstrates broad host range infectivity against multidrug-resistant bacteria

18. Modified defence peptides from horseshoe crab target and kill bacteria inside host cells

19. MicroPIPE: validating an end-to-end workflow for high-quality complete bacterial genome construction

20. Fine tuning the mechanism of Antigen 43 self-association to modulate aggregation levels of Escherichia coli pathogens

21. Mycobacterium tuberculosisrequires glyoxylate shunt and reverse methylcitrate cycle for lactate and pyruvate metabolism

22. A Retrospective Study Using the String of Pearls Tibial Plateau Levelling Osteotomy Locking Plate for the Treatment of Cranial Cruciate Ligament Disease

23. Uropathogenic Escherichia coli employs both evasion and resistance to subvert innate immune-mediated zinc toxicity for dissemination

24. Short‐term Oral Steroids Significantly Improves Chronic Rhinosinusitis Without Nasal Polyps

25. Genomic surveillance, characterization and intervention of a polymicrobial multidrug-resistant outbreak in critical care

26. Discovery of Bacterial Fimbria–Glycan Interactions Using Whole-Cell Recombinant Escherichia coli Expression

27. Characterization of DtrJ as an IncC plasmid conjugative DNA transfer component

28. MicroPIPE: An end-to-end solution for high-quality complete bacterial genome construction

30. Genomic surveillance, characterisation and intervention of a carbapenem-resistant Acinetobacter baumannii outbreak in critical care

31. An alloy of zinc and innate immunity: Galvanising host defence against infection

32. Strain and lineage-level methylome heterogeneity in the multi-drug resistant pathogenic Escherichia coli ST101 clone

33. Restriction of chronic Escherichia coli urinary tract infection depends upon T cell-derived interleukin-17, a deficiency of which predisposes to flagella-driven bacterial persistence

34. Repurposing a neurodegenerative disease drug to treat Gram-negative antibiotic-resistant bacterial sepsis

35. Integrating multiple genomic technologies to investigate an outbreak of carbapenemase-producing Enterobacter hormaechei

36. Genomic analysis of carbapenemase-producing

37. Intensive infection control responses and whole genome sequencing to interrupt and resolve widespread transmission of OXA-181 Escherichia coli in a hospital setting

38. Genomic characterisation and context of the blaNDM-1 carbapenemase in Escherichia coli ST101

39. The urinary microbiome in patients with refractory urge incontinence and recurrent urinary tract infection

40. Modifications in the pmrB gene are the primary mechanism for the development of chromosomally encoded resistance to polymyxins in uropathogenic Escherichia coli

41. Biofilms 2015: Multidisciplinary Approaches Shed Light into Microbial Life on Surfaces

42. Uncovering novel susceptibility targets to enhance the efficacy of third-generation cephalosporins against ESBL-producing uropathogenic Escherichia coli

44. Variation in hemolysin A expression between uropathogenic

45. Uropathogenic

46. Global gene expression profiling of a virulent Klebsiella pneumoniae strain during pulmonary infection

47. Crystal structure of Mycobacterium tuberculosis ketol‐acid reductoisomerase at 1.0 Å resolution – a potential target for anti‐tuberculosis drug discovery

48. Salmonella employs multiple mechanisms to subvert the TLR‐inducible zinc‐mediated antimicrobial response of human macrophages

49. Clay nanoparticles co-deliver three antigens to promote potent immune responses against pathogenic Escherichia coli

50. Identification and Characterization of a Phase-Variable Element That Regulates the Autotransporter UpaE in Uropathogenic Escherichia coli

Catalog

Books, media, physical & digital resources